Background
HD, sudden death, arrhythmia
EVENTS, SUDDEN DEATH, ARRHYTHMIA, HEART FAILURE
Patients receiving maintenance hemodialysis (HD) have a high incidence of cardiovascular events, including arrhythmia and sudden death. Spironolactone reduces the risk of cardiovascular events and sudden death in patients with heart failure, but the effects of spironolactone on arrhythmic events in patients treated with maintenance HD are unclear.